Spinal Tech Archives - Page 807 of 1229

Biologic Therapies gets FDA clearance for bone marrow cannulas — 5 key notes

Biologic Therapies received U.S. Food and Drug Administration clearance for the Bio-MAC and Bio-CORE Bone Marrow Cannulas.

Northland gives K2M "Outperform" rating — 5 things to know

A new group of analysts initiated coverage of K2M shares, according to a WKRB News & Analysis report.

Stryker gets new "Outperform" rating — 5 key notes

Stryker has a new group of analysts covering their stock, according to a Sleek Monkey report.

6 highlights from Bone Therapeutics in Q1 — Poised for US growth

Brussels-based Bone Therapeutics reported first quarter results.

Smith & Nephew acquires software for supply chain optimization: 4 takeaways

Smith & Nephew has acquired two software assets from S2 Interactive.

LDR, MEDTECH, Paradigm Spine & more — 14 key notes

Here are 14 key notes on spine and orthopedic device companies this week.

Vinita Bali buys 2.4k Smith & Nephew shares — 5 key notes

Vinita Bali, a Smith & Nephew insider, purchased several shares on the open market yesterday, according to a Sleek Monkey report.

BONESUPPORT receives Frost & Sullivan award for CERAMENT — 4 observations

BONESUPPORT received the Frost & Sullivan 2015 Growth Capital Investment Award.

Spinal Kinetics M6 disc replacement: Good results 2 years postop: 5 key notes

Spinal Kinetics presented the results of a two-year, multi-center outcomes trial for treating lumbar degenerative disc disease using the company's Spinal Kinetics M6 cervical disc prosthesis.

MiMedx Group's CollaFix fibers can assist tendon regeneration: 4 key takeaways

MiMedx Group announced that the publication of its peer-reviewed scientific study, which proves the link between the properties of its CollaFix fibers and beginning of tendon regeneration.